Zomedica Corp. (AMEX:ZOM) price on Thursday, August 26, rose 18.96% above its previous day’s close as an upside momentum from buyers pushed the stock’s value to $0.69.
A look at the stock’s price movement, the close in the last trading session was $0.58, moving within a range at $0.66 and $0.80. The beta value (5-Year monthly) was 0.32. Turning to its 52-week performance, $2.91 and $0.06 were the 52-week high and 52-week low respectively. Overall, ZOM moved 8.13% over the past month.
Zomedica Corp.’s market cap currently stands at around $652.81 million, with investors looking forward to this quarter’s earnings report slated for Aug 09, 2021 – Aug 13, 2021.
Revisions could be used as tool to get short term price movement insight, and for the company that in the past seven days was no upward and no downward review(s). Turning to the stock’s technical picture we see that short term indicators suggest on average that ZOM is a 50% Sell. On the other hand, the stock is on average a 50% Sell as suggested by medium term indicators while long term indicators are putting the stock in 100% Sell category.
1 analyst(s) have given their forecast ratings for the stock on a scale of 1.00-5.00 for a strong buy to strong sell recommendation. A total of 0 analyst(s) rate the stock as a Hold, 1 recommend ZOM as a Buy and 0 give it an Overweight rating. Meanwhile, 0 analyst(s) rate the stock as Underweight and 0 say it is a Sell. As such, the average rating for the stock is Buy which could provide an opportunity for investors keen on increasing their holdings of the company’s stock.
ZOM’s current price about 27.02% and 4.14% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 63.77, while 7-day volatility ratio is 14.06% and 8.25% in the 30-day chart. Further, Zomedica Corp. (ZOM) has a beta value of 0.34, and an average true range (ATR) of 0.06. Analysts have given the company’s stock an average 52-week price target of $1.20, forecast between a low of $1.20 and high of $1.20. Looking at the price targets, the low is -73.91% off current price level while to achieve the yearly target high, price needs to move -73.91%. Nonetheless, investors will most likely welcome a -73.91% jump to $1.20 which is the analysts’ median price.
In the market, a comparison of Zomedica Corp. (ZOM) and its peers suggest the former has performed considerably stronger. Data shows ZOM’s intraday price has changed 18.96% in last session and 467.52% over the past year. Elsewhere, the overall performance for the S&P 500 and Dow Jones Industrial shows that the indexes are down -0.58% and -0.54% respectively in the last trading.
If we refocus on Zomedica Corp. (AMEX:ZOM), historical trading data shows that trading volumes averaged 21.46 million over the past 10 days and 28.71 million over the past 3 months. The company’s latest data on shares outstanding shows there are 973.66 million shares.
The 0.30% of Zomedica Corp.’s shares are in the hands of company insiders while institutional holders own 15.60% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 72.09 million on Jun 29, 2021, giving us a short ratio of 1.9. The data shows that as of Jun 29, 2021 short interest in Zomedica Corp. (ZOM) stood at 7.37% of shares outstanding, with shares short rising to 59.4 million registered in May 27, 2021. Current price change has pushed the stock 199.26% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the ZOM stock continues to rise going into the next quarter.